ProKidney Corp.
ProKidney Corp.
Your view on PROK
Overview
What the company does, where it operates, and who runs it.
About ProKidney Corp.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Bruce Culleton
- Headquarters
- 2000 Frontis Plaza Blvd., Winston-Salem, NC, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Bruce Culleton
- Headquarters
- 2000 Frontis Plaza Blvd., Winston-Salem, NC, US
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.